FMR LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 55 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.

Quarter-by-quarter ownership
FMR LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,169
+173.9%
422
+222.1%
0.00%
Q2 2023$1,157
-37.9%
131
-41.5%
0.00%
Q1 2023$1,864
+73.4%
224
+100.0%
0.00%
Q4 2022$1,075
+7.5%
1120.0%0.00%
Q3 2022$1,0000.0%1120.0%0.00%
Q2 2022$1,0000.0%1120.0%0.00%
Q1 2022$1,0001120.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders